Bioerodible injectable poly(ortho ester) for tetracycline controlled delivery to periodontal pockets: Preliminary trial in humans

AAPS PharmSci

Volumn 4, Issue 4, 2002, Pages

  Schwach Abdellaoui, K ^a   Loup, P J ^a   Vivien Castioni, N ^a   Mombelli, A ^a   Baehni, P ^a   Barr, J ^b   Heller, J ^b   Gurny, R ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b AP Pharma   (United States)

Author keywords

Bioerodible polymers; Controlled release; Periodonitis; Poly(ortho esters); Sustained delivery; System; Tetracycline

Indexed keywords

BUFFER; PHOSPHATE; POLY(ORTHO ESTER); POLYMER; TETRACYCLINE;

CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DEGRADATION KINETICS; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG RETENTION; DRUG TISSUE LEVEL; DRUG TOLERABILITY; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLAR TOOTH; PAIN ASSESSMENT; PERIODONTAL DISEASE; PERIODONTITIS; PH; PREVENTIVE DENTISTRY; RECURRENT DISEASE; REVIEW; TEMPERATURE; TIME; TOOTH ROOT; TREATMENT OUTCOME;

EID: 85046914565     PISSN: 15221059     EISSN: None     Source Type: Journal    
DOI: 10.1208/ps040420     Document Type: Review

References (27)

1. Van Winkelhoff AJ, Winkel EG. Periodontal infections and treatment. J Parodontol Implantol Orale. 1996;15:219-232.
2. Moore WEC, Moore LVH. The bacteria of periodontal diseases. Periodontology. 1994;2000:66-77.
3. Baehni PC. Supportive care of the periodontal patient. Curr Opin Periodontol. 1997; 4:151-157.
4. Mombelli A, Schmid B, Rutar A, Lang NP. Persistence patterns of Porphyromonas gingivalis, Prevotella intermedia/nigriscens, and Actinobacillus actinomycetemcomitans after mechanical therapy of periodontal disease. J Periodontol. 2000;71:14-21.
5. Lindhe J, Nyman S. Long-term maintenance of patients treated for advanced periodontal disease. J Clin Periodontol. 1984;11:504-514.
6. Goodson JM. Antimicrobial strategies for treatment of periodontal diseases. Periodontology. 1994;5:142-168.
7. Smith SR, Foyle DM, Needleman IG, Pandya NV. The role of antibiotics in the treatment of periodontitis (Part I - Systemic Delivery). Eur J Prosthodont Rest Dent. 1998;3:79-86.
8. Addy M, Renton-Harper P. Local and systemic chemotherapy in the management of periodontal disease: an opinion and review of the concept. J Oral Rehabilitation. 1996;23:219-231.
9. Mombelli A, Van Winkelhoff AJ. The systemic use of antibiotics in periodontal therapy. In: Lang NP, Karring T, Lindhe J, eds. Proceedings of the Second European Workshop on Periodontology-Chemicals in Periodontics. Thurgau, Switzerland: Charterhouse ET Ittingen; 1997:38-77.
10. O'Connor BC, Newman HN, Wilson M. Susceptibility and resistance of plaque bacteria to minocycline. J Periodontol. 1990;61:228-233.
11. Larsen T, Fiehn NE. Development of resistance to metronidazole and minocycline in vitro. J Clin Periodontol. 1997;24:254-259.
12. Goodson JM, Holborow D, Dunn RL, Hogan P, Dunham S. Monolithic tetracycline containing fibers for controlled delivery to periodontal pockets. J Periodontol. 1983; 54:575-579.
13. Schwach-Abdellaoui K, Vivien-Castioni N, Gurny R. Local delivery of antimicrobial agents for the treatment of periodontal diseases. Eur J Pharm Biopharm. 2000;50:83-99.
14. Drisko CL, Cobb CM, Killoy WJ, et al. Evaluation of periodontal treatments using controlled release tetracycline fibers. Clinical response. J Periodontol. 1995;66:692-699.
15. Higashi K, Matsushita M, Morisaki K, Hayashi SI, Mayumi T. Local drug delivery systems for the treatment of periodontal disease. J Pharmacobio Dyn. 1991;14:72-81.
16. Stoltze K. Elimination of Elyzol 25% Dentalgel matrix from periodontal pockets. J Clin Periodontol. 1995;22:185-187.
17. Nakagawa T, Yamada S, Oosuka Y, et al. Clinical and microbiological study of local minocycline delivery (PERIOCLINE ) following scaling and root planing in recurrent periodontal pockets. Bull Tokyo Dent Coll. 1991;32:63-70.
18. Vandekerckhove BNA, Quirynen M, VanSteenberghe D. The use of tetracycline-containing controlled release fibers in the treatment of refractory periodontitis. J Periodontol. 1997;68:353-361.
19. Schwach-Abdellaoui K, Heller J, Gurny R. Synthesis and characterization of self-catalyzed poly(ortho esters) based on decanediol and decanediol-lactate. J Biomater Sci Polymer Edn. 1999;10:375-389.
20. Sintzel MB, Heller J, Ng SY, Taylor MS, Tabatabay C, Gurny R. Synthesis and characterization of self-catalyzed poly(ortho esters). Biomaterials. 1998;19:791-800.
21. Schwach-Abdellaoui K, Heller J, Gurny R. Hydrolysis and erosion studies of autocatalyzed poly(ortho esters) containing lactoyl-lactyl acid dimers. Macromolecules. 1999;32:301-307.
22. Ng SY, Shen HR, Lopez E, et al. Development of poly(ortho ester) prototype with a latent acid in the polymer backbone for 5-fluorouracil delivery. J Controlled Release. 2000;65:367-374.
23. Sintzel MB, Heller J, Ng SY, Tabatabay C, Schwach-Abdellaoui K, Gurny R. In vitro drug release from self catalyzed poly(ortho ester): Case study of 5-fluorouracil. J Controlled Release. 1998;55:213-218.
24. Schwach-Abdellaoui K, Heller J, Barr J, Gurny R. Control of molecular weight for auto-catalyzed poly(ortho ester) obtained by polycondensation reaction. Int J Polym Anal Character. In press.
25. Schwach-Abdellaoui K, Monti A, Heller J, Gurny R. Optimization of a novel bioerodible device based on auto-catalyzed poly(ortho esters) for controlled delivery of tetracycline to periodontal pocket. Biomaterials. 2001;22:1659-1666.
26. Merkli A, Heller J, Tabatabay C, Gurny R. Semi-solid hydrophobic bioerodible poly (ortho ester) for potential application in glaucoma filtering surgery. J Controlled Release. 1994;29:105-112.
27. Roskos KV, Fritzinger BK, Rao SS, Armitage GC, Heller J. Development of a drug delivery system for the treatment of periodontal disease based on bioerodible poly(ortho esters). Biomaterials. 1995;16: 313-317.